| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Radiation Dosage | 5 | 2018 | 585 | 0.86 | Why? |
| Phantoms, Imaging | 3 | 2017 | 146 | 0.75 | Why? |
| Body Composition | 3 | 2018 | 414 | 0.68 | Why? |
| Radiography, Abdominal | 1 | 2017 | 88 | 0.66 | Why? |
| Clothing | 1 | 2017 | 100 | 0.62 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2017 | 869 | 0.60 | Why? |
| Network Meta-Analysis | 1 | 2018 | 426 | 0.60 | Why? |
| Radiography, Interventional | 1 | 2017 | 158 | 0.60 | Why? |
| Electrocardiography | 6 | 2021 | 3957 | 0.45 | Why? |
| Ventricular Function, Left | 5 | 2021 | 1555 | 0.42 | Why? |
| Signal Processing, Computer-Assisted | 2 | 2021 | 193 | 0.36 | Why? |
| Artificial Intelligence | 5 | 2021 | 3543 | 0.36 | Why? |
| Heart Rate | 4 | 2021 | 1527 | 0.35 | Why? |
| Immunization, Passive | 11 | 2021 | 10067 | 0.35 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.34 | Why? |
| Multiple Pulmonary Nodules | 2 | 2018 | 115 | 0.32 | Why? |
| Stroke Volume | 5 | 2019 | 2153 | 0.31 | Why? |
| Liver Neoplasms | 4 | 2018 | 1666 | 0.30 | Why? |
| Software | 1 | 2017 | 2501 | 0.30 | Why? |
| Image Processing, Computer-Assisted | 4 | 2018 | 1383 | 0.29 | Why? |
| Pulmonary Edema | 2 | 2019 | 430 | 0.27 | Why? |
| Erythrocyte Transfusion | 2 | 2017 | 386 | 0.25 | Why? |
| Tomography, X-Ray Computed | 8 | 2018 | 25144 | 0.24 | Why? |
| Exercise Test | 2 | 2019 | 911 | 0.24 | Why? |
| Plasma | 3 | 2021 | 1809 | 0.24 | Why? |
| Ventricular Dysfunction, Left | 2 | 2021 | 993 | 0.22 | Why? |
| Plantar Plate | 1 | 2019 | 1 | 0.20 | Why? |
| Arthropathy, Neurogenic | 1 | 2019 | 1 | 0.20 | Why? |
| Breast Neoplasms, Male | 1 | 2019 | 48 | 0.20 | Why? |
| Foot Ulcer | 1 | 2019 | 22 | 0.19 | Why? |
| Glucagon | 1 | 2018 | 52 | 0.19 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.19 | Why? |
| Osteosarcoma | 1 | 2019 | 83 | 0.19 | Why? |
| C-Peptide | 1 | 2018 | 77 | 0.18 | Why? |
| Heat-Shock Response | 1 | 2018 | 47 | 0.18 | Why? |
| Ezetimibe | 1 | 2018 | 50 | 0.18 | Why? |
| Parenchymal Tissue | 1 | 2018 | 61 | 0.18 | Why? |
| Pain Threshold | 1 | 2018 | 46 | 0.18 | Why? |
| Blood Platelet Disorders | 1 | 2018 | 44 | 0.18 | Why? |
| Epidermis | 1 | 2018 | 47 | 0.18 | Why? |
| Carcinoma, Hepatocellular | 2 | 2018 | 1222 | 0.18 | Why? |
| Nerve Fibers | 1 | 2018 | 73 | 0.17 | Why? |
| Myocardial Contraction | 1 | 2019 | 123 | 0.17 | Why? |
| Pericardiectomy | 1 | 2017 | 21 | 0.17 | Why? |
| Solitary Pulmonary Nodule | 1 | 2018 | 83 | 0.17 | Why? |
| Echo-Planar Imaging | 1 | 2017 | 27 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.17 | Why? |
| Diagnostic Techniques, Neurological | 1 | 2017 | 46 | 0.17 | Why? |
| Fluoroscopy | 1 | 2017 | 140 | 0.17 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 162 | 0.17 | Why? |
| Polyneuropathies | 1 | 2019 | 157 | 0.17 | Why? |
| Molecular Imaging | 1 | 2018 | 110 | 0.16 | Why? |
| Upper Extremity | 1 | 2019 | 193 | 0.16 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.16 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 112 | 0.16 | Why? |
| Pulmonary Surfactant-Associated Protein D | 1 | 2018 | 129 | 0.16 | Why? |
| Actigraphy | 1 | 2017 | 102 | 0.16 | Why? |
| Proprotein Convertase 9 | 1 | 2018 | 141 | 0.16 | Why? |
| Heart Failure | 4 | 2019 | 6638 | 0.16 | Why? |
| Metabolism | 1 | 2017 | 74 | 0.16 | Why? |
| Amyloid Neuropathies, Familial | 1 | 2017 | 77 | 0.16 | Why? |
| Calibration | 1 | 2017 | 307 | 0.16 | Why? |
| Oligonucleotides | 1 | 2017 | 137 | 0.16 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.15 | Why? |
| Bone Neoplasms | 1 | 2019 | 287 | 0.15 | Why? |
| Neural Conduction | 2 | 2017 | 261 | 0.15 | Why? |
| Laser Therapy | 1 | 2018 | 158 | 0.15 | Why? |
| Breast | 1 | 2018 | 290 | 0.15 | Why? |
| Safety | 2 | 2020 | 1583 | 0.15 | Why? |
| Radiculopathy | 1 | 2016 | 79 | 0.15 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.15 | Why? |
| Sheep | 1 | 2017 | 420 | 0.15 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2018 | 385 | 0.15 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.14 | Why? |
| Kidney Calculi | 1 | 2016 | 62 | 0.14 | Why? |
| Hyperlipidemias | 1 | 2017 | 290 | 0.14 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.14 | Why? |
| Radiographic Image Enhancement | 1 | 2015 | 89 | 0.14 | Why? |
| Wound Healing | 1 | 2019 | 424 | 0.14 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
| Elasticity Imaging Techniques | 1 | 2017 | 194 | 0.14 | Why? |
| Spatio-Temporal Analysis | 1 | 2021 | 1182 | 0.14 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.14 | Why? |
| Polycystic Ovary Syndrome | 1 | 2017 | 151 | 0.14 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.14 | Why? |
| Hemodynamics | 2 | 2019 | 1562 | 0.13 | Why? |
| Muscle, Skeletal | 2 | 2018 | 915 | 0.13 | Why? |
| Neurologists | 1 | 2017 | 283 | 0.13 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2019 | 436 | 0.13 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.13 | Why? |
| Accreditation | 1 | 2015 | 203 | 0.13 | Why? |
| Humans | 52 | 2021 | 930598 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.12 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.12 | Why? |
| Middle Aged | 29 | 2021 | 270681 | 0.12 | Why? |
| Protein Biosynthesis | 1 | 2017 | 653 | 0.12 | Why? |
| Circadian Rhythm | 1 | 2018 | 607 | 0.12 | Why? |
| Electrodiagnosis | 1 | 2013 | 152 | 0.12 | Why? |
| Interleukin-8 | 1 | 2018 | 964 | 0.12 | Why? |
| Male | 35 | 2021 | 367725 | 0.12 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.12 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Aged | 25 | 2021 | 215776 | 0.11 | Why? |
| Adult | 24 | 2021 | 244371 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.11 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.10 | Why? |
| Female | 33 | 2021 | 380317 | 0.10 | Why? |
| Hot Temperature | 1 | 2018 | 1299 | 0.10 | Why? |
| Pulmonary Wedge Pressure | 2 | 2019 | 53 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Predictive Value of Tests | 6 | 2021 | 9537 | 0.10 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.10 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.09 | Why? |
| Heart | 1 | 2019 | 1791 | 0.09 | Why? |
| Academic Medical Centers | 1 | 2021 | 3088 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.09 | Why? |
| Exercise | 2 | 2019 | 6771 | 0.09 | Why? |
| Aged, 80 and over | 13 | 2021 | 88759 | 0.09 | Why? |
| United States | 8 | 2021 | 46150 | 0.09 | Why? |
| Death Certificates | 1 | 2009 | 130 | 0.08 | Why? |
| Cardiac Surgical Procedures | 2 | 2018 | 1931 | 0.08 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.08 | Why? |
| Tumor Burden | 2 | 2019 | 369 | 0.08 | Why? |
| Liver | 2 | 2018 | 4007 | 0.08 | Why? |
| Perioperative Care | 1 | 2017 | 1329 | 0.08 | Why? |
| Research Design | 3 | 2017 | 5830 | 0.08 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.08 | Why? |
| ROC Curve | 4 | 2021 | 6024 | 0.08 | Why? |
| Atrial Fibrillation | 2 | 2018 | 2320 | 0.08 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.08 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.08 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 1510 | 0.08 | Why? |
| Case-Control Studies | 6 | 2021 | 17671 | 0.07 | Why? |
| Lung Diseases, Interstitial | 1 | 2017 | 1476 | 0.07 | Why? |
| Signal-To-Noise Ratio | 2 | 2017 | 217 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.07 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.07 | Why? |
| Observer Variation | 2 | 2017 | 622 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Spinal Cord Injuries | 1 | 2009 | 270 | 0.07 | Why? |
| Obesity | 3 | 2019 | 7388 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Heart Diseases | 1 | 2021 | 3503 | 0.06 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Blood Glucose Self-Monitoring | 2 | 2018 | 791 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.06 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Echocardiography | 3 | 2019 | 3661 | 0.05 | Why? |
| Antigenic Variation | 1 | 2021 | 249 | 0.05 | Why? |
| Transfusion-Related Acute Lung Injury | 1 | 2020 | 63 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.05 | Why? |
| Glucocorticoids | 1 | 2016 | 4431 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.05 | Why? |
| Proportional Hazards Models | 3 | 2019 | 6543 | 0.05 | Why? |
| Diet, Reducing | 1 | 2019 | 38 | 0.05 | Why? |
| Perfusion | 1 | 2020 | 254 | 0.05 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.05 | Why? |
| Breast Density | 1 | 2018 | 5 | 0.05 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.05 | Why? |
| Small Fiber Neuropathy | 1 | 2018 | 14 | 0.05 | Why? |
| CA-19-9 Antigen | 1 | 2018 | 22 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.05 | Why? |
| Pancreas, Artificial | 1 | 2017 | 10 | 0.05 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Isolated Heart Preparation | 1 | 2017 | 3 | 0.04 | Why? |
| Transfusion Reaction | 1 | 2020 | 245 | 0.04 | Why? |
| Amino Acids, Branched-Chain | 1 | 2017 | 8 | 0.04 | Why? |
| Lung | 4 | 2019 | 31049 | 0.04 | Why? |
| Shear Strength | 1 | 2017 | 17 | 0.04 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
| Ventricular Pressure | 1 | 2017 | 25 | 0.04 | Why? |
| Sex Hormone-Binding Globulin | 1 | 2017 | 57 | 0.04 | Why? |
| Residual Volume | 1 | 2017 | 45 | 0.04 | Why? |
| Total Lung Capacity | 1 | 2017 | 40 | 0.04 | Why? |
| Pulmonary Circulation | 1 | 2019 | 207 | 0.04 | Why? |
| Muscle Proteins | 1 | 2017 | 64 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| Preoperative Period | 1 | 2018 | 271 | 0.04 | Why? |
| Subcutaneous Fat | 1 | 2018 | 94 | 0.04 | Why? |
| Synovial Cyst | 1 | 2016 | 3 | 0.04 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2021 | 368 | 0.04 | Why? |
| Heart Atria | 1 | 2019 | 267 | 0.04 | Why? |
| Lumbosacral Region | 1 | 2016 | 30 | 0.04 | Why? |
| Triamcinolone | 1 | 2016 | 24 | 0.04 | Why? |
| Spinal Stenosis | 1 | 2016 | 22 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Intervertebral Disc Displacement | 1 | 2016 | 25 | 0.04 | Why? |
| Injections, Epidural | 1 | 2016 | 45 | 0.04 | Why? |
| Betamethasone | 1 | 2016 | 63 | 0.04 | Why? |
| Operative Time | 1 | 2018 | 450 | 0.04 | Why? |
| Forecasting | 2 | 2021 | 4492 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Fitness Trackers | 1 | 2017 | 120 | 0.04 | Why? |
| Methylation | 1 | 2017 | 332 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.04 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.04 | Why? |
| Animals | 4 | 2018 | 78931 | 0.04 | Why? |
| Aorta | 1 | 2018 | 355 | 0.04 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2020 | 694 | 0.04 | Why? |
| Insulin Infusion Systems | 1 | 2017 | 256 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2019 | 48226 | 0.04 | Why? |
| Insurance Coverage | 1 | 2019 | 348 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Cause of Death | 1 | 2009 | 4823 | 0.03 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.03 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2019 | 711 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Mammography | 1 | 2018 | 410 | 0.03 | Why? |
| Health Status | 2 | 2018 | 3259 | 0.03 | Why? |
| Adiposity | 1 | 2017 | 329 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Time-to-Treatment | 2 | 2021 | 5883 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Reaction Time | 1 | 2013 | 96 | 0.03 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.03 | Why? |
| Spirometry | 1 | 2017 | 524 | 0.03 | Why? |
| Physical Fitness | 1 | 2017 | 334 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Weight Loss | 1 | 2019 | 826 | 0.03 | Why? |
| Disability Evaluation | 1 | 2017 | 671 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.03 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Judgment | 1 | 2013 | 98 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2019 | 639 | 0.03 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.03 | Why? |
| Fibrosis | 1 | 2016 | 800 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2016 | 1027 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
| Socioeconomic Factors | 2 | 2019 | 8495 | 0.03 | Why? |
| Child | 2 | 2019 | 70012 | 0.03 | Why? |
| Action Potentials | 1 | 2013 | 368 | 0.03 | Why? |
| Sex Distribution | 1 | 2019 | 2083 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Testosterone | 1 | 2017 | 596 | 0.03 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.03 | Why? |
| Patient Reported Outcome Measures | 1 | 2017 | 912 | 0.03 | Why? |
| Long QT Syndrome | 1 | 2021 | 1047 | 0.03 | Why? |
| Diabetes Mellitus | 1 | 2013 | 8207 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| False Positive Reactions | 1 | 2016 | 1338 | 0.03 | Why? |
| Health Behavior | 1 | 2009 | 4449 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.03 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.02 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.02 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.02 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.02 | Why? |
| Vascular Surgical Procedures | 1 | 2018 | 882 | 0.02 | Why? |
| Smartphone | 1 | 2021 | 1840 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Reference Standards | 1 | 2013 | 1163 | 0.02 | Why? |
| Bariatric Surgery | 1 | 2019 | 1298 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.02 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.02 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.02 | Why? |
| Diagnostic Imaging | 1 | 2016 | 1044 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Swine | 1 | 2016 | 3352 | 0.02 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.02 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.02 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.02 | Why? |
| Rehabilitation Centers | 1 | 2009 | 252 | 0.02 | Why? |
| Time Factors | 3 | 2017 | 31397 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Recovery of Function | 1 | 2016 | 2461 | 0.02 | Why? |
| Sleep | 1 | 2018 | 2695 | 0.02 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.02 | Why? |
| Dexamethasone | 1 | 2016 | 2055 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.02 | Why? |
| African Americans | 1 | 2019 | 3363 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.02 | Why? |
| International Cooperation | 1 | 2017 | 3436 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2019 | 3893 | 0.01 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.01 | Why? |
| Societies, Medical | 1 | 2015 | 6907 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |